Literature DB >> 1487617

Increase in triglycerides during alpha-interferon treatment of chronic viral hepatitis.

M Ruiz-Moreno, V Carreño, M J Rúa, T Cotonat, B Serrano, M Santos, E Marriott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1487617     DOI： 10.1016/s0168-8278(05)80675-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

Review 1.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

Review 2.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.